São Paulo - Delayed Quote BRL

Walgreens Boots Alliance, Inc. (WGBA34.SA)

Compare
27.14 +0.04 (+0.15%)
At close: November 29 at 6:05 PM GMT-3
Loading Chart for WGBA34.SA
DELL
  • Previous Close 27.10
  • Open 27.68
  • Bid 26.88 x --
  • Ask 27.14 x --
  • Day's Range 26.79 - 27.92
  • 52 Week Range 22.80 - 66.17
  • Volume 533
  • Avg. Volume 2,345
  • Market Cap (intraday) 46.931B
  • Beta (5Y Monthly) 0.67
  • PE Ratio (TTM) --
  • EPS (TTM) -30.11
  • Earnings Date Jan 1, 2025 - Jan 5, 2025
  • Forward Dividend & Yield 1.89 (6.98%)
  • Ex-Dividend Date Nov 14, 2024
  • 1y Target Est --

Walgreens Boots Alliance, Inc. operates as a healthcare, pharmacy, and retail company in the United States, Germany, the United Kingdom, and internationally. It operates through three segments: U.S. Retail Pharmacy, International, and U.S. Healthcare. The U.S. Retail Pharmacy segment engages in operation of the retail drugstores, health and wellness services, specialty, and home delivery pharmacy services, which offers health and wellness, beauty, personal care and consumables, and general merchandise. The International segment offers sale of prescription drugs and health and wellness, beauty, personal care, and other consumer products outside the United States; and operates pharmacy-led health and beauty retail businesses under the Boots brand stores in the United Kingdom, the Republic of Ireland, and Thailand, as well as the Benavides brand in Mexico and the Ahumada brand in Chile. The U.S. Healthcare segment provides VillageMD, a national provider of value-based care with primary, multi-specialty, and urgent care providers serving patients in traditional clinic settings, in patients' homes and online appointments; Shields, a specialty pharmacy integrator and accelerator for hospitals; and CareCentrix, a participant in the post-acute and home care management sectors. Walgreens Boots Alliance, Inc. was founded in 1909 and is headquartered in Deerfield, Illinois.

www.walgreensbootsalliance.com

193,000

Full Time Employees

August 31

Fiscal Year Ends

Healthcare

Sector

Pharmaceutical Retailers

Industry

Recent News: WGBA34.SA

View More

Compare To: WGBA34.SA

Select to analyze similar companies using key performance metrics; select up to 4 stocks.

Statistics: WGBA34.SA

View More

Valuation Measures

Annual
As of 11/29/2024
  • Market Cap

    46.92B

  • Enterprise Value

    225.89B

  • Trailing P/E

    --

  • Forward P/E

    5.50

  • PEG Ratio (5yr expected)

    --

  • Price/Sales (ttm)

    0.05

  • Price/Book (mrq)

    0.75

  • Enterprise Value/Revenue

    0.25

  • Enterprise Value/EBITDA

    --

Financial Highlights

Profitability and Income Statement

  • Profit Margin

    -5.85%

  • Return on Assets (ttm)

    0.59%

  • Return on Equity (ttm)

    -75.97%

  • Revenue (ttm)

    147.66B

  • Net Income Avi to Common (ttm)

    -8.64B

  • Diluted EPS (ttm)

    -30.11

Balance Sheet and Cash Flow

  • Total Cash (mrq)

    3.11B

  • Total Debt/Equity (mrq)

    277.90

  • Levered Free Cash Flow (ttm)

    2.73B

Research Analysis: WGBA34.SA

View More

Company Insights: WGBA34.SA

Research Reports: WGBA34.SA

View More

People Also Watch